Results 21 to 30 of about 73,934 (325)

Cardiac tamponade: an educational review.

open access: yesEuropean heart journal. Acute cardiovascular care, 2020
Cardiac tamponade is a pericardial syndrome characterised by an impairment of the diastolic filling of the ventricles causing reduction of cardiac output, usually producing signs and symptoms of cardiac arrest, if untreated.
M. Imazio, G. D. de Ferrari
semanticscholar   +1 more source

Infantile pericardial round cell tumor

open access: yesAnnals of Pediatric Cardiology, 2015
Cardiac malignancies presenting in infancy are rare. Desmoplastic small round cell tumor (DSRCT) is a rare occurrence in this age group. No case of intrapericardial DSRCT has been reported in the literature in infants.
K H Sridevi   +4 more
doaj   +1 more source

Foveal Microvascular Structures in Eyes with Silicone Oil Tamponade for Rhegmatogenous Retinal Detachment: A Swept-source Optical Coherence Tomography Angiography Study

open access: yesScientific Reports, 2020
Silicone oil (SO) is widely used as a long-term intravitreal tamponading agent for rhegmatogenous retinal detachment (RRD) repair. This study investigated the structural changes of the foveal microvasculature using optical coherence tomography ...
Jong Young Lee   +4 more
semanticscholar   +1 more source

Cardiac tamponade in a patient supported by veno-arterial extracorporeal membrane oxygenation

open access: yesAnnals of Cardiac Anaesthesia, 2022
Cardiac tamponade occurring in a patient supported on central veno-arterial extracorporeal membrane oxygenation is depicted in a transesophageal echocardiography image and associated rendering.
Troy G Seelhammer   +3 more
doaj   +1 more source

Purulent pericardial effusion in children: Experience from a tertiary care center in North India

open access: yesAnnals of Pediatric Cardiology, 2020
Background: Purulent pericarditis, if not recognized and managed timely, it can lead to significant morbidity and mortality. There are no guidelines for the management of purulent pericardial effusion in pediatric patients.
Anika Agrawal   +4 more
doaj   +1 more source

Restrictive physiology masked by cardiac tamponade: A rare cooccurrence in a child with lymphoblastic T-cell lymphoma

open access: yesAnnals of Pediatric Cardiology, 2022
Cardiac involvement in T-cell lymphoma is not uncommon. Pericardial effusion is the most common manifestation of cardiac involvement with restrictive cardiomyopathy (RCM) due to tumor infiltration being extremely rare.
Atit A Gawalkar   +5 more
doaj   +1 more source

Mediastinal debulking for a T-cell leukaemia/lymphoma presenting with cardiac tamponade

open access: yesMonaldi Archives for Chest Disease, 2019
Anterior mediastinal masses are relatively uncommon and include a wide variety of lesions. Lymphomas account for 25% of anterior mediastinal masses. Lymphomas and other haematological malignancies are associated with pericardial effusion.
Sotirios D. Moraitis   +6 more
doaj   +1 more source

Characteristics, fates and complications of long-term silicone oil tamponade after pars plana vitrectomy

open access: yesBMC Ophthalmology, 2020
Background Silicone oil tamponade has become a mainstay in treatment of advanced retinal detachment due to multiple etiologies. The aim of this study is to assess the characteristics, fates and complications of long-term silicone oil tamponade after par ...
N. Abu-Yaghi   +9 more
semanticscholar   +1 more source

Comparison of fundus changes following silicone oil and sterilized air tamponade for macular-on retinal detachment patients

open access: yesBMC Ophthalmology, 2020
Background To investigate different tamponade effects of intravitreal silicone oil (SO) and sterilized air on macular vasculature and structure after successful retinal repair for macular-on rhegmatogenous retinal detachment (RRD) patients.
Yifan Zhou   +5 more
semanticscholar   +1 more source

Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases

open access: yesFrontiers in Oncology, 2019
Background: Nivolumab is an immune checkpoint inhibitor (ICI) that has shown efficacy for treating non-small cell lung cancer and has become a standard therapy for previously treated non-small cell lung cancer.
Masahiro Yamasaki   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy